Genetics, Genomics and Emerging Molecular Therapies of Pancreatic Cancer

Genetics, Genomics and Emerging Molecular Therapies of Pancreatic Cancer

The number of cases of pancreatic cancers in 2019 in Poland was 3852 (approx. 2% of all cancers). The course of the disease is very fast, and the average survival time from the diagnosis is 6 months. Only <2% of patients live for 5 years from the diagnosis, 8% live for 2 years, and almost half li...

Full description

Bibliographic Details
Main Authors: Jakub Liu, Magdalena Mroczek, Anna Mach, Maria Stępień, Angelika Aplas, Bartosz Pronobis-Szczylik, Szymon Bukowski, Magda Mielczarek, Ewelina Gajewska, Piotr Topolski, Zbigniew J. Król, Joanna Szyda, Paula Dobosz
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Cancers
Subjects:
pancreatic cancer
genetics
genomics
molecular therapies
Online Access:https://www.mdpi.com/2072-6694/15/3/779

Internet

https://www.mdpi.com/2072-6694/15/3/779

Similar Items